Journal article
Cost-Effectiveness of the Implantable Cardioverter-Defibrillator
Abstract
BACKGROUND: In the Canadian Implantable Defibrillator Study (CIDS), we assessed the cost-effectiveness of the implantable cardioverter-defibrillator (ICD) in reducing the risk of death in survivors of previous ventricular tachycardia (VT) or fibrillation (VF).
METHODS AND RESULTS: Healthcare resource use was collected prospectively on the first 430 patients enrolled in CIDS (n=212 ICD, n=218 amiodarone). Mean cost per patient, adjusted for …
Authors
O’Brien BJ; Connolly SJ; Goeree R; Blackhouse G; Willan A; Yee R; Roberts RS; Gent M
Journal
Circulation, Vol. 103, No. 10, pp. 1416–1421
Publisher
Wolters Kluwer
Publication Date
March 13, 2001
DOI
10.1161/01.cir.103.10.1416
ISSN
0009-7322